Considerations for clinical pharmacology studies for biologics in emerging markets.
about
Considerations for clinical pharmacology studies for biologics in emerging markets.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Considerations for clinical pharmacology studies for biologics in emerging markets.
@en
type
label
Considerations for clinical pharmacology studies for biologics in emerging markets.
@en
prefLabel
Considerations for clinical pharmacology studies for biologics in emerging markets.
@en
P2093
P2860
P356
P1476
Considerations for clinical pharmacology studies for biologics in emerging markets.
@en
P2093
Bharat Damle
Huifen Faye Wang
Robert White
P2860
P304
P356
10.1002/JCPH.403
P478
55 Suppl 3
P577
2015-03-01T00:00:00Z